Twist Bioscience (TWST) - Stock Price & Dividends

Twist Bioscience Corp (NASDAQ:TWST) specializes in creating and selling synthetic DNA-based products. These products include synthetic genes and gene fragments utilized in therapeutics, diagnostics, food, agriculture, data storage, and academic research across various industries like biotech, pharmaceuticals, industrial chemicals, and agriculture.

In addition to synthetic genes, the company offers oligo pools used in Next-Generation Sequencing (NGS), CRISPR gene editing, DNA origami, and DNA computing. They also provide immunoglobulin G proteins for customers focused on drug discovery.

Furthermore, Twist Bioscience provides NGS tools such as library preparation kits and human exome kits for diagnostic tests, population genetics research, and biomarker discovery. They also offer methylation detection kits for cancer and rare diseases, as well as synthetic RNA reference sequences to aid in the development of assays for various viruses, including SARS-CoV-2.

The company's product line extends to synthetic SARS-CoV-2 Research Panels and precision DNA libraries used in antibody engineering and optimization processes. Founded in 2013, Twist Bioscience is headquartered in South San Francisco, California.

For more information, you can visit their website at https://www.twistbioscience.com.